Zhang, Qian
Zhou, Renpeng
Yang, Jingjing
Dou, Changlin
Gan, Tianyi
Liu, Fujia
Hu, Baihui
Song, Deyong
Lu, Chao
Clinical trials referenced in this document:
Documents that mention this clinical trial
A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Clinical Trial to Assess Safety, Tolerability, and Pharmacokinetics of LY-CovMab, a Potent Human Neutralizing Antibody Against SARS-CoV-2
https://doi.org/10.1007/s40121-021-00572-x
Funding for this research was provided by:
National Major Scientific and Technological Special Project (2020ZX09201014)
Article History
Received: 1 November 2021
Accepted: 23 November 2021
First Online: 8 December 2021